Dibrompropamidine
CAS 496-00-4
Dibrompropamidine (CAS 496-00-4) is a Phase 2 pharmaceutical compound with 4 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Clinical Development Phase
Highest clinical development phase rendered from the matched compound identifier rows.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | Ki | 1187.75 nM | 4 | - |
| - | Potency | 18105.6 nM | 1 | - |
| Urokinase-type plasminogen activator Enzyme |
Ki | 5.8 | - | Homo sapiens |
| Prothrombin Enzyme |
Ki | 6.02 | - | Homo sapiens |
| Suppressor of tumorigenicity 14 protein Enzyme |
Ki | 6.27 | - | Homo sapiens |
| Acrosin Enzyme |
Ki | 5.77 | - | Sus scrofa |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Dibrompropamidine used for in pharmaceutical contexts?
Dibrompropamidine (CAS 496-00-4) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Dibrompropamidine?
No adverse-event association or SIDER side-effect rows are rendered for Dibrompropamidine in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Dibrompropamidine also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Dibromopropamidine Diisethionate with EU status "permitted".
What clinical phase is Dibrompropamidine in?
Dibrompropamidine is rendered with ChEMBL max phase 2.
What bioactivity targets are documented for Dibrompropamidine?
Dibrompropamidine has 6 bioactivity rows in this page query. Rendered target entries include Urokinase-type plasminogen activator, Prothrombin, Suppressor of tumorigenicity 14 protein, Acrosin.